Ocular toxicity from high-dose cytosine arabinoside

Cancer ◽

10.1002/1097-0142(19830201)51:3<430::aid-cncr2820510313>3.0.co;2-5 ◽

1983 ◽

Vol 51 (3) ◽

pp. 430-432 ◽

Author(s):

Paul S. Ritch ◽

Richard M. Hansen ◽

Dale K. Heuer

Keyword(s):

Cytosine Arabinoside ◽

High Dose ◽

Ocular Toxicity

Download Full-text

Effects of the Rational Use of Corticosteroids Eye Drops for the Prevention of Ocular Toxicity in High-Dose Cytosine Arabinoside Therapy

YAKUGAKU ZASSHI ◽

10.1248/yakushi1947.119.3_229 ◽

1999 ◽

Vol 119 (3) ◽

pp. 229-235 ◽

Author(s):

Mizuki ITOH ◽

Takao AOYAMA ◽

Yoshikazu YAMAMURA ◽

Katsuyoshi NAKAJIMA ◽

Kouichi NAKAMURA ◽

...

Keyword(s):

Cytosine Arabinoside ◽

High Dose ◽

Eye Drops ◽

Ocular Toxicity ◽

Download Full-text

OCULAR TOXICITY AFTER INADVERTENT INTRACAMERAL INJECTION OF HIGH DOSE OF CEFUROXIME DURING CATARACT SURGERY

Retinal Cases & Brief Reports ◽

10.1097/icb.0000000000000577 ◽

2019 ◽

Vol 13 (3) ◽

pp. 269-272 ◽

Author(s):

Radua Kamal-Salah ◽

Olayinka Osoba ◽

Edward Doyle

Keyword(s):

Cataract Surgery ◽

High Dose ◽

Ocular Toxicity ◽

Intracameral Injection

Download Full-text

Antiemetic Therapy in Patients Treated with High-Dose Cytosine Arabinoside

Oncology ◽

10.1159/000226452 ◽

1987 ◽

Vol 44 (2) ◽

pp. 90-92 ◽

Author(s):

John B. Craig ◽

Bayard L. Powell ◽

Douglas R. White ◽

Robert L. Capizzi

Keyword(s):

Cytosine Arabinoside ◽

Antiemetic Therapy ◽

Download Full-text

BONE MARROW TRANSPLANTATION FOLLOWING BUSULFAN, CYCLOPHOSPHAMIDE AND HIGH DOSE CYTOSINE-ARABINOSIDE AS TREATMENT FOR INFANTS WITH TRANSLOCATION (4;11) ACUTE LEUKAEMIA

British Journal of Haematology ◽

10.1111/j.1365-2141.1989.tb07702.x ◽

1989 ◽

Vol 72 (2) ◽

pp. 293-294 ◽

Author(s):

P. Bordigoni ◽

E. Benz-Lemoine ◽

J. P. Vannier ◽

A. Fischer

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Cytosine Arabinoside ◽

Marrow Transplantation ◽

Acute Leukaemia ◽

Download Full-text

Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin

Annals of Hematology ◽

10.1007/s002770050379 ◽

1998 ◽

Vol 76 (3-4) ◽

pp. 145-151 ◽

Author(s):

G. Seipelt ◽

W.-K. Hofmann ◽

H. Martin ◽

B. Wassmann ◽

A. Boehme ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

High Dose ◽

Download Full-text

Randomized Comparison of Sequential High-Dose Cytosine Arabinoside and Idarubicin (S-HAI) with or without Chemo-Modulation by Fludarabine in Refractory and Relapsed Acute Myeloid Leukemia

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias VIII ◽

10.1007/978-3-642-18156-6_92 ◽

2001 ◽

pp. 578-587

Author(s):

W. Kern ◽

A. Matylis ◽

T. Grüneisen ◽

C. Huber ◽

A. Grote-Metke ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

High Dose ◽

Relapsed Acute Myeloid Leukemia ◽

Download Full-text

Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias VII ◽

10.1007/978-3-642-71960-8_133 ◽

1998 ◽

pp. 954-962

Author(s):

W. Kern ◽

C. Aul ◽

G. Maschmeyer ◽

R. Schönrock-Nabulsi ◽

A. Kerkhoff ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

High Dose ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Stimulating Factor ◽

Download Full-text

Superiority of High-Dose over Intermediate-Dose Cytosine Arabinoside (AraC) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia (AML)

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias VII ◽

10.1007/978-3-642-71960-8_132 ◽

1998 ◽

pp. 943-953

Author(s):

W. Kern ◽

C. Aul ◽

G. Maschmeyer ◽

R. Schönrock-Nabulsi ◽

W. D. Ludwig ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

High Dose ◽

Acute Myeloid ◽

Intermediate Dose

Download Full-text

Treatment of Minimal Residual Disease in “Poor Risk” Acute Lymphoblastic Leukaemia with High-Dose Cytosine Arabinoside

Minimal Residual Disease in Acute Leukemia 1986 ◽

10.1007/978-94-009-4273-8_19 ◽

1986 ◽

pp. 205-210 ◽

Author(s):

M. J. Barnett ◽

J. E. Kingston ◽

A. Miller ◽

A. Z. S. Rohatiner ◽

M. A. Horton ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Cytosine Arabinoside ◽

Residual Disease ◽

High Dose ◽

Poor Risk ◽

Minimal Residual

Download Full-text

High-Dose Cytosine-Arabinoside Plus AMSA for Reinduction or Consolidation-Maintenance in Acute Myelogenous Leukemia

Minimal Residual Disease in Acute Leukemia 1986 ◽

10.1007/978-94-009-4273-8_15 ◽

1986 ◽

pp. 159-166

Author(s):

R. Zittoun

Keyword(s):

Cytosine Arabinoside ◽

Acute Myelogenous Leukemia ◽

Myelogenous Leukemia ◽

High Dose ◽

Acute Myelogenous

Download Full-text